Tác động của bệnh kèm theo đến kết quả ở người nhận ghép thận: một nghiên cứu hồi cứu tại Italy

Alonso A, Oliver J (2004) Chronic allograft nephropathy: causes of death and mortality risk factors-a review of the last decade in Spain. Transplant Proc 36:765–767 Liefeldt L, Budde K (2010) Risk factors for cardiovascular disease in renal transplant recipients and strategies to minimize risk. Transpl Int 23:1191–1204 Dimeny EM (2002) Cardiovascular disease after renal transplantation. Kidney Int 61:S78–S84 Kasiske BL, Chakkera HA, Roel J (2000) Explained and unexplained ischemic heart disease risk after renal transplantation. J Am Soc Nephrol 11:1735–1743 Lindholm A, Albrechtsen D, Frodin L et al (1995) Ischemic heart disease—major cause of death and graft loss after renal transplantation in Scandinavia. Transplantation 60:451–457 Ojo AO, Hanson JA, Wolfe RA et al (2000) Long-term survival in renal transplant recipients with graft function. Kidney Int 57:307–313 Wolfe RA, Ashby VB, Milford EL et al (1999) Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 341:1725–1730 Kasiske BL, Israni AK, Snyder JJ, Skeans MA (2011) Patient Outcomes in Renal Transplantation (PORT) Investigators. The relationship between kidney function and long-term graft survival after kidney transplant. Am J Kidney Dis 57:466–475 Parfrey PS, Harnett JD, Foley RN et al (1995) Impact of renal transplantation on uremic cardiomyopathy. Transplantation 60:908–914 Hernandez D, Lacalzada J, Rufino M et al (1997) Prediction of left ventricular mass changes after renal transplantation by polymorphism of the angiotensin-converting enzyme gene. Kidney Int 51:1205–1211 Peteiro J, Alvarez N, Calvino R et al (1994) Changes in left ventricular mass and filling after renal transplantation are related to changes in blood pressure: an echocardiographic and pulsed Doppler study. Cardiology 85:273–283 Hüting J (1992) Course of left ventricular hypertrophy and function in end-stage renal disease after renal transplantation. Am J Cardiol 70:1481–1484 Himelman RB, Landzberg JS, Simonson JS et al (1988) Cardiac consequences of renal transplantation: changes in left ventricular morphology and function. J Am Coll Cardiol 12:915–923 Neale J, Smith AC (2015) Cardiovascular risk factors following renal transplant. World J Transplant 24(5):183–195 Sarnak MJ, Levey AS (2000) Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis 35(4 Suppl 1):S117–S131 Jensik SC (1998) Tacrolimus (FK 506) in kidney transplantation: three-year survival results of the US multicenter, randomized, comparative trial. FK 506 Kidney Transplant Study Group. Transplant Proc 30:1216–1218 Midvedt K, Neumayer HH (2003) Management strategies for posttransplant hypertension. Transplantation 70(11 Suppl):SS64–SS69 Fellström B (2000) Impact and management of hyperlipidemia posttransplantation. Transplantation 70(11 Suppl):SS51–SS57 Jindal RM, Hjelmesaeth J (2000) Impact and management of posttransplant diabetes mellitus. Transplantation 70(11 Suppl):SS58–SS63 Fabbian F, Pala M, De Giorgi A et al (2013) In-hospital mortality in patients with renal dysfunction admitted for myocardial infarction: the Emilia-Romagna region of Italy database of hospital admissions. Int Urol Nephrol 45:769–775 Fabbian F, Gallerani M, Pala M et al (2014) Association between in-hospital mortality and renal dysfunction in 186,219 patients hospitalized for acute stroke in the Emilia-Romagna region of Italy. Angiology 65:906–910 Fabbian F, Gallerani M, Pala M et al (2013) In-hospital mortality for pulmonary embolism: relationship with chronic kidney disease and end-stage renal disease. The hospital admission and discharge database of the Emilia Romagna region of Italy. Intern Emerg Med 8:735–740 Terasaki PI (2003) Deduction of the fraction of immunologic and non-immunologic failure in cadaver donor transplant. Clin transpl 449–452 Elixhauser A, Steiner C, Harris DR, Coffey RM (1998) Comorbidity measures for use with administrative data. Med Care 36:8–27 Quan H, Sundararajan V, Halfon P et al (2005) Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 43:1130–1139 Paterno F, Wilson GC, Wima K et al (2014) Hospital utilization and consequences of readmissions after liver transplantation. Surgery 156:871–878 Hernández D, de la Nuez PC, Muriel A et al (2014) Clinical assessment of mortality risk in renal transplant candidates in Spain. Transplantation 98:653–659 Daratha KB, Short RA, Corbett CF et al (2012) Risks of subsequent hospitalization and death in patients with kidney disease. Clin J Am Soc Nephrol 7:409–416 Segev DL, Kucirka LM, Oberai PC et al (2009) Age and comorbidities are effect modifiers of gender disparities in renal transplantation. J Am Soc Nephrol 20:621–628 Wu C, Evans I, Joseph R et al (2005) Comorbid conditions in kidney transplantation: association with graft and patient survival. J Am Soc Nephrol 16:3437–3444 Baskin-Bey ES, Kremers W, Nyberg SL (2007) A recipient risk score for deceased donor renal allocation. Am J Kidney Dis 49:284–293 Karim A, Farrugia D, Cheshire J et al (2014) Recipient age and risk for mortality after kidney transplantation in England. Transplantation 97:832–838 Grosso G, Corona D, Mistretta A et al (2012) Predictive value of the Charlson comorbidity index in kidney transplantation. Transplant Proc 44:1859–1863 USRDS (2011) Transpantation. http://www.usrds.org/2011/pdf/v2_ch07_11.pdf. Accessed 25 Sept 2015 Meier-Kriesche HU, Baliga R, Kaplan B (2003) Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation. Transplantation 75:1291–1295 Israni AK, Snyder JJ, Skeans MA et al (2010) Predicting coronary heart disease after kidney transplantation: patient outcomes in Renal Transplantation (PORT) Study. Am J Transplant 10:338–353 Weiner DE, Carpenter MA, Levey AS et al (2012) Kidney function and risk of cardiovascular disease and mortality in kidney transplant recipients: the FAVORIT trial. Am J Transplant 12:2437–2445 Jardine AG, Fellström B, Logan JO et al (2005) Cardiovascular risk and renal transplantation: post hoc analyses of the Assessment of Lescol in Renal Transplantation (ALERT) Study. Am J Kidney Dis 46:529–536 Machnicki G, Pinsky B, Takemoto S et al (2009) Predictive ability of pretransplant comorbidities to predict long-term graft loss and death. Am J Transplant 9:494–505 Gagne JJ, Glynn RJ, Avorn J, Levin R, Schneeweiss S (2011) A combined comorbidity score predicted mortality in elderly patients better than existing scores. J Clin Epidemiol 64:749–759 Weinhandl ED, Snyder JJ, Israni AK, Kasiske BL (2009) Effect of comorbidity adjustment on CMS criteria for kidney transplant center performance. Am J Transplant 9:506–516 Harhay M, Lin E, Pai A et al (2013) Early rehospitalization after kidney transplantation: assessing preventability and prognosis. Am J Transplant 13:3164–3172 Schultz MA, van Servellen G, Chang BL, McNeese-Smith D, Waxenberg E (1998) The relationship of hospital structural and financial characteristics to mortality and length of stay in acute myocardial infarction patients. Outcomes Manag Nurs Pract 2:130–136 Rosenthal GE (1997) Weak association between hospital mortality rates for individual diagnoses: implications for profiling hospital quality. Am J Public Health 87:429–433 Wallace E, Stuart E, Vaughan N, Bennett K, Fahey T, Smith SM (2014) Risk prediction models to predict emergency hospital admission in community-dwelling adults: a systematic review. Med Care 52:751–765 Athyros VG, Katsiki N, Karagiannis A, Mikhailidis DP (2015) Statins can improve proteinuria and glomerular filtration rate loss in chronic kidney disease patients, further reducing cardiovascular risk. Fact or fiction? Expert Opin Pharmacother 16:1449–1461